DocuSign, Inc. (NASDAQ:DOCU) Stock Holdings Reduced by Mitsubishi UFJ Trust & Banking Corp

Mitsubishi UFJ Trust & Banking Corp reduced its position in DocuSign, Inc. (NASDAQ:DOCU) by 8.4% during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 183,670 shares of the company’s stock after selling 16,851 shares during the period. Mitsubishi UFJ Trust & Banking Corp owned about 0.09% of DocuSign worth $16,519,000 at the end of the most recent quarter.

Other hedge funds and other institutional investors also recently made changes to their positions in the company. The Manufacturers Life Insurance Company lifted its stake in DocuSign by 2.4% in the third quarter. The Manufacturers Life Insurance Company now owns 53,508 shares of the company’s stock valued at $3,322,000 after acquiring an additional 1,248 shares during the last quarter. FMR LLC lifted its stake in shares of DocuSign by 16.8% in the 3rd quarter. FMR LLC now owns 2,192,885 shares of the company’s stock valued at $136,156,000 after purchasing an additional 315,073 shares during the last quarter. Brooklyn Investment Group bought a new stake in DocuSign in the third quarter worth $33,000. Townsquare Capital LLC increased its position in DocuSign by 3.7% during the third quarter. Townsquare Capital LLC now owns 5,103 shares of the company’s stock worth $317,000 after buying an additional 183 shares during the last quarter. Finally, Freedom Investment Management Inc. bought a new position in DocuSign during the third quarter valued at about $201,000. 77.64% of the stock is owned by hedge funds and other institutional investors.

DocuSign Price Performance

Shares of DOCU stock opened at $83.18 on Friday. DocuSign, Inc. has a one year low of $48.70 and a one year high of $107.86. The stock has a fifty day moving average price of $87.18 and a 200 day moving average price of $81.17. The stock has a market cap of $16.84 billion, a P/E ratio of 17.15, a price-to-earnings-growth ratio of 6.94 and a beta of 1.02.

DocuSign (NASDAQ:DOCU) last released its quarterly earnings data on Thursday, March 13th. The company reported $0.86 EPS for the quarter, topping analysts’ consensus estimates of $0.84 by $0.02. The company had revenue of $776.25 million during the quarter, compared to the consensus estimate of $760.94 million. DocuSign had a net margin of 34.73% and a return on equity of 14.90%. The firm’s revenue for the quarter was up 9.0% compared to the same quarter last year. During the same period last year, the firm earned $0.76 EPS. Equities research analysts anticipate that DocuSign, Inc. will post 1.17 EPS for the current year.

Analysts Set New Price Targets

Several analysts have recently issued reports on DOCU shares. Hsbc Global Res upgraded DocuSign to a “moderate sell” rating in a research note on Friday, December 6th. Needham & Company LLC reiterated a “hold” rating on shares of DocuSign in a report on Friday, March 14th. Wedbush restated a “neutral” rating and issued a $100.00 price objective on shares of DocuSign in a research note on Friday, March 14th. HSBC reiterated a “reduce” rating on shares of DocuSign in a research note on Friday, December 6th. Finally, UBS Group cut their target price on shares of DocuSign from $100.00 to $90.00 and set a “neutral” rating for the company in a research report on Friday, March 14th. Two research analysts have rated the stock with a sell rating, nine have assigned a hold rating and four have assigned a buy rating to the company. According to data from MarketBeat.com, the company has a consensus rating of “Hold” and an average target price of $95.00.

Insider Activity

In other news, Director Teresa Briggs sold 534 shares of the business’s stock in a transaction on Monday, March 17th. The shares were sold at an average price of $87.41, for a total value of $46,676.94. Following the sale, the director now owns 8,270 shares in the company, valued at approximately $722,880.70. The trade was a 6.07 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, CEO Allan C. Thygesen sold 40,000 shares of the stock in a transaction dated Thursday, January 2nd. The stock was sold at an average price of $90.04, for a total transaction of $3,601,600.00. Following the sale, the chief executive officer now owns 156,050 shares of the company’s stock, valued at $14,050,742. This trade represents a 20.40 % decrease in their position. The disclosure for this sale can be found here. In the last ninety days, insiders have sold 97,851 shares of company stock worth $8,579,369. Company insiders own 1.66% of the company’s stock.

DocuSign Profile

DocuSign, Inc provides electronic signature solution in the United States and internationally. The company provides e-signature solution that enables sending and signing of agreements on various devices; Contract Lifecycle Management (CLM), which automates workflows across the entire agreement process; Document Generation streamlines the process of generating new, custom agreements; and Gen for Salesforce, which allows sales representatives to automatically generate agreements with a few clicks from within Salesforce.